NCT03278431View on ClinicalTrials.gov

Triple Combinations Against Hookworm Infections in Lao

PHASE4CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

September 27, 2017

Primary Completion Date

November 17, 2017

Study Completion Date

December 1, 2017

Conditions
Hookworm Infection
Interventions
DRUG

Albendazole

Albendazole (400 mg) from Janssen, donated by the World Health Organization

DRUG

Pyrantel Pamoate

Pyrantel pamoate (20 mg/kg), will be purchased by the World Health Organization

DRUG

Oxantel Pamoate

Oxantel pamoate (20mg/kg) will be produced by the University of Basel

DRUG

Mebendazole

Mebendazole (500 mg) from GlaxoSmithKline, donated by the World Health Organization

Trial Locations (1)

0604

Nambak District Hospital, Luang Prabang

All Listed Sponsors
lead

Swiss Tropical & Public Health Institute

OTHER

NCT03278431 - Triple Combinations Against Hookworm Infections in Lao | Biotech Hunter | Biotech Hunter